JW Pharmaceutical (XKRX:001060) Common Stock : ₩58,215 Mil (As of Mar. 2024)

View and export this data going back to 1976. Start your Free Trial

What is JW Pharmaceutical Common Stock?

JW Pharmaceutical's quarterly common stock stayed the same from Sep. 2023 (₩57,088 Mil) to Dec. 2023 (₩57,088 Mil) but then increased from Dec. 2023 (₩57,088 Mil) to Mar. 2024 (₩58,215 Mil).

JW Pharmaceutical's annual common stock increased from Dec. 2021 (₩53,850 Mil) to Dec. 2022 (₩55,445 Mil) and increased from Dec. 2022 (₩55,445 Mil) to Dec. 2023 (₩57,088 Mil).

JW Pharmaceutical Common Stock Historical Data

The historical data trend for JW Pharmaceutical's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW Pharmaceutical Common Stock Chart

JW Pharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

50,795.06

52,300.14

53,849.82

55,445.20

57,087.59

JW Pharmaceutical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Common Stock	Get a 7-Day Free Trial															57,087.59	57,087.59	57,087.59	57,087.59	58,214.83

JW Pharmaceutical Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

JW Pharmaceutical (XKRX:001060) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Pharmaceutical (XKRX:001060) » Definitions » Common Stock

Traded in Other Exchanges

001067:Korea 001065.PFD:Korea

Address

2477, Nambusunhwan-ro, Seocho-gu, KOR

Website

https://www.jw-pharma.co.kr

JW Pharmaceutical is active in the healthcare sector. It has been one of the leading companies in the pharmaceutical market on a global basis. Its original medicine and medical supply pipeline include Livalo, Thrupas, Sigmart and Actemra. It also develops low-protein and low-salt diet food for patients suffering from chronic renal insufficiency as well as general Pharmaceuticals and health care products.

JW Pharmaceutical (XKRX:001060) Headlines

No Headlines